Medi-Cal Update

Obstetrics | September 2018 | Bulletin 531

Print Medi-Cal Update
 

1. April 2018 HCPCS Quarterly Update: Policy Updates

Effective for dates of service on or after April 1, 2018, the following HCPCS codes are Medi-Cal benefits:

HCPCS Code Description
C9462 Injection, delafloxacin, 1 mg
C9463 Injection, aprepitant, 1 mg
C9464 Injection, rolapitant, 0.5 mg
C9466 Injection, benralizumab, 1 mg
C9749 Repair of nasal vestibular lateral wall stenosis with implant(s)
Q2041 Axicabtagene ciloleucel, up to 200 million autologous anti-CD19 CAR T Cells, including leukapheresis and dose preparation procedures, per infusion
Q5103 Injection, infliximab-dyyb, biosimilar, (Inflectra), 10 mg
Q5104 Injection, infliximab-abda, biosimilar, (Renflexis), 10 mg

In addition, codes Q5103 and Q5104 replace terminated code Q5102 (injection, infliximab, biosimilar, 10 mg).

This information is reflected in the following provider manual(s):

Provider Manual(s) Page(s) Updated
AIDS Waiver Program
Audiology and Hearing Aids
Durable Medical Equipment
Expanded Access to Primary Care Program
Home Health Agencies/Home and Community-Based Services
Local Educational Agency
Medical Transportation
Orthotics and Prosthetics
Therapies
Vision Care
modif app (21)
Chronic Dialysis Clinics inject cd list (2, 3, 5, 9, 14); inject drug a-d (13–15, 48, 49); inject drug e-h (22); inject drug i-m (8–12); modif app (21)
Clinics and Hospitals
General Medicine
chemo drug a-d (2, 3, 7, 8); chemo drug p-z (10); inject cd list (2, 3, 5, 9, 14); inject drug a-d (13–15, 48, 49); inject drug e-h (22); inject drug i-m (8–12); modif app (21); non ph (11, 13, 24, 26)
Obstetrics
Rehabilitation Clinics
inject cd list (2, 3, 5, 9, 14); inject drug a-d (13–15, 48, 49); inject drug e-h (22); inject drug i-m (8–12); modif app (21); non ph (11, 13, 24, 26)
Pharmacy inject cd list (2, 3, 5, 9, 14); inject drug a-d (13–15, 48, 49); inject drug e-h (22); inject drug i-m (8–12)
Print Article | Return to Top
 

2. July 2018 HCPCS Quarterly Update: Policy Updates

Effective for dates of service on or after July 1, 2018, the following HCPCS codes are Medi-Cal benefits:

HCPCS Code Description
C9030 Injection, copanlisib, 1 mg
C9031 Lutetium Lu 177, dotatate, therapeutic, 1 mCi
C9032 Injection, voretigene neparvovec-rzyl, 1 billion vector genomes
Q9991 Injection, buprenorphine extended-release (Sublocade), less than or equal to 100 mg
Q9992 Injection, buprenorphine extended-release (Sublocade), greater than 100 mg

In addition, code C9469 (injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg) has been terminated.

This information is reflected in the following provider manual(s):

Provider Manual(s) Page(s) Updated
Chronic Dialysis Clinics inject cd list (3, 4, 10, 16); inject drug a-d (23–26); inject drug s-z (21, 22); modif used (12)
Clinics and Hospitals
General Medicine
chemo drug a-d (22, 23); chemo drug e-o (19); inject cd list (3, 4, 10, 16); inject drug a-d (23–26); inject drug s-z (21, 22); modif used (12); non ph (11, 13); once (1); presum (19)
Obstetrics inject cd list (3, 4, 10, 16); inject drug a-d (23–26); inject drug s-z (21, 22); modif used (12); non ph (11, 13); once(1); presum (19)
Pharmacy inject cd list (3, 4, 10, 16); inject drug a-d (23–26); inject drug s-z (21, 22); presum (19)
Rehabilitation Clinics inject cd list (3, 4, 10, 16); inject drug a-d (23–26); inject drug s-z (21, 22); modif used (12); non ph (11, 13)
Print Article | Return to Top
 

3. 2018 ICD-10-CM Diagnosis Code Annual Update

Effective retroactively for dates of service on or after October 1, 2017, the ICD-10-CM diagnosis codes have been updated. Certain ICD-10-CM diagnosis codes have been expanded for greater detail, deactivated or revised.

An Erroneous Payment Correction (EPC) will be implemented to reprocess affected claims. No action is required of providers.

Information and downloads for these codes can be found on the 2018 ICD-10-CM and GEMs web page of the CMS website.

This information is reflected in the following provider manual(s):

Provider Manual(s) Page(s) Updated
Chronic Dialysis Clinics medi non cpt (2); inject drug a-d (15)
Clinics and Hospitals
General Medicine
chemo drug a-d (11); ev woman (18); fam planning (8); gene coun (3); inject drug a-d (15); medi non cpt (2); medne neu (6); minor (5); ophthal (9); ophthal cd (2, 3, 5, 6, 8); path molec (16, 59); preg early (8–16); preg fetal (1); radi dia ult (1); surg nerv (1)
Inpatient Services minor (5)
Obstetrics ev woman (18); fam planning (8); gene coun (3); inject drug a-d (15); medi non cpt (2); minor (5); path molec (16, 59); preg early (8–16); preg fetal (1); radi dia ult (1)
Pharmacy
Rehabilitation Clinics
inject drug a-d (15)
Vision Care eyeglass lens (6); low vision (2); medi non cpt (2); minor (5); pro serv cd (2, 5, 6, 8); rates max optom (5)
Print Article | Return to Top
 

4. 2019 ICD-10-CM/PCS Diagnosis Code Annual Update

Effective for dates of service on or after October 1, 2018, the Centers for Medicare & Medicaid Services (CMS) has added ICD-10-CM and ICD-10-PCS diagnosis codes for the 2019 ICD-10-CM/PCS annual update.

Information and downloads for these codes can be found at the ICD-10 page of the CMS website. Specific billing policy related to this update will be published in a future Medi-Cal Update.

Print Article | Return to Top
 

5. Implementation Delay: Automated Hemogram and RSV Laboratory Tests

An article published in the May 2018 Medi-Cal Update, titled Automated Hemogram and RSV Laboratory Tests Added as CLIA-Waived Services, informed providers that certain services are reimbursable as Clinical Laboratory Improvement Amendments (CLIA)-waived tests when performed with a CLIA-waived test kit and billed with modifier QW (CLIA waived test). The article erroneously lists the effective date as June 1, 2018. Due to a delay in implementation, this policy is effective for dates of service on or after October 1, 2018.

No action is required of providers. An Erroneous Payment Correction (EPC) will be implemented to reprocess affected claims.

Print Article | Return to Top
 

6. New Fetal Non-Stress Testing Benefit and Guidelines

Effective for dates of service on or after October 1, 2018, CPT-4 code 76819 (fetal biophysical profile; without non-stress testing) is a reimbursable Medi-Cal benefit limited to high-risk pregnancies. When billing for CPT-4 code 76819 or CPT-4 code 59025 (fetal non-stress test), providers are required to use an appropriate antepartum high-risk ICD-10-CM diagnosis code within the range of O09.211 – O9A.513.

Reimbursement for CPT-4 code 76819 is limited to once per week, but may be billed more than five times in nine months, when billed in conjunction with one of the ICD-10-CM diagnosis codes in the following table:

ICD-10-CM
Diagnosis Code
Description
O09.212 – O09.293 Pregnancy with other poor reproductive history
O09.892, O09.893 Supervision of other high risk pregnancy
O24.011 – O24.919 Diabetes mellitus in pregnancy
O36.5120 – O36.5939 Maternal care for known or suspected poor fetal growth
O36.8920 – O36.8999 Maternal care for other specified fetal problems
O42.112, O42.113 Preterm premature rupture of membranes

CPT-4 code 76819 may be split-billed with modifier 26 (professional component) or TC (technical component). When billing for both the professional and technical service components, a modifier is neither required nor allowed. CPT-4 code 76819 may not be billed with modifier 51 (multiple procedures).

Additionally, CPT-4 code 76819 is a benefit for the Presumptive Eligibility for Pregnant Women (PE4PW) program.

This information is reflected in the following provider manual(s):

Provider Manual(s) Page(s) Updated
Clinics and Hospitals
General Medicine
Obstetrics
preg early (18, 19); presum (9)
Pharmacy presum (9)
Print Article | Return to Top
 

7. Whole-Child Model Program Implementing in Select Counties

Senate Bill 586 authorizes the Department of Health Care Services (DHCS) to establish the Whole-Child Model (WCM) program in designated County Organized Health Systems (COHS) or Regional Health Authority counties to incorporate California Children’s Services (CCS) program covered services for Medi-Cal eligible CCS children and youth into a Medi-Cal Managed Care Plan (MCP) contract. Under WCM, MCPs assume full financial responsibility for authorization and payment of CCS program-eligible medical services, including authorization activities, claims payments and processing, case management and quality oversight.

Effective July 1, 2018, Phase 1 of the WCM program is implemented in the following counties:

As of the transition date, the CCS program-eligible medical services in WCM counties are carved into MCPs’ capitated rate for those counties. In addition, MCPs are required to cover and ensure the provision of screening, preventive and medically necessary diagnostic and treatment services for clients under the age of 21, including Early and Periodic Screening, Diagnosis and Treatment. CCS program State-Only children with other health coverage will continue to receive services the way they do today and remain the responsibility of the counties.

Service Authorization Requests (SARs) received by WCM CCS programs before June 30, 2018, for Phase 1 are the responsibility of the county to complete. All SARs for services after the Phase 1 WCM start date of July 1, 2018, are to be sent to the MCPs. For the purpose of continuity of care, SARs approved before the transition to MCPs shall remain valid until the end date of the authorization or until the MCPs complete an assessment of the client’s needs. Services carved-out of the MCPs contract are the responsibility of DHCS and will be authorized by DHCS. SARs for carve-out services received by CCS programs or MCPs should be routed to DHCS for authorization.

Providers rendering services for WCM clients should submit their claims directly to the MCP for services rendered on or after July 1, 2018, for Phase 1. Carve-out services authorized by DHCS should be billed to DHCS accordingly. Providers not part of the MCP network are encouraged to become part of the MCP’s provider network. MCPs are required to pay physician and surgeon provider services at rates that are at least equal to the applicable CCS fee-for-service rates unless the physician and surgeon enter into an agreement on an alternative payment methodology mutually agreed upon by the physician, surgeon and the MCP.

DHCS issued additional guidance on California Children’s Services Program Whole Child Model Numbered Letter 04-0618 and the Whole Child Model Provider Notice. Both documents are posted on the California Children’s Services (CCS) Whole-Child Model (WCM) page of the DHCS website. Providers can contact their respective COHS plan provider services should they have any claims or billing inquires.

County COHS Phone Number
Merced, Monterey,
Santa Cruz
Central California Alliance for Health 1-800-700-3874 TTY/TDD
1-877-548-0857
San Luis Obispo,
Santa Barbara
CenCal Health 1-877-814-1861 TTY
1-833-556-2560
San Mateo Health Plan of San Mateo (650) 616-2500 TTY
(650) 616-8037
Print Article | Return to Top
 

8. IncobotulinumtoxinA Benefit Expanded for Treatment of Upper Limb Spasticity

Effective retroactively for dates of service on or after March 1, 2018, incobotulinumtoxinA (HCPCS code J0588) benefit is expanded for use in the treatment of upper limb spasticity. The allowable dosage is up to 400 units no sooner than every 12 weeks. Reimbursement requires an approved Treatment Authorization Request (TAR) that includes clinical documentation of the following:

IncobotulinumtoxinA injection services rendered by physician assistants and nurse practitioners are reimbursable as appropriate.

This information is reflected in the following provider manual(s):

Provider Manual(s) Page(s) Updated
Clinics and Hospitals
General Medicine
Obstetrics
Rehabilitation Clinics
inject drug a-d (18, 19); non ph (11)
Chronic Dialysis Clinics
Pharmacy
inject drug a-d (18, 19)
Print Article | Return to Top
 

9. TAR Criteria Reminder for Dental Conscious and Deep Sedation

On November 1, 2015, new criteria and guidelines were developed for intravenous (I.V.) conscious sedation/analgesia Current Dental Terminology (CDT) codes D9241 and D9242, and deep sedation/general anesthesia CDT codes D9220 and D9221. These policies are in effect for the entirety of Medi-Cal dental procedures regarding I.V. and general anesthesia services. Providers rendering general anesthesia and I.V. sedation services are required to submit a Treatment Authorization Request (TAR). Additional documentation justifying the medical necessity for I.V. sedation or general anesthesia is also required.

The dental treatment plan flowchart released in the July 2017 Denti-Cal bulletin is a resource for providers to use in conjunction with the I.V. sedation and general anesthesia policy under the “Intravenous (I.V.) Sedation and General Anesthesia Guidelines for Dental Procedures” heading and “Criteria Indications for I.V. Sedation or General Anesthesia” subheading in the Anesthesia section in the appropriate Part 2 manual. The flowchart was developed to ensure that providers are submitting appropriate documentation to justify the medical necessity of I.V. sedation or general anesthesia. Providers should refer to this flowchart when submitting the required additional documentation that is specific to each case. If a dental treatment plan is available, it should be included with the justification for I.V. sedation or general anesthesia.

Print Article | Return to Top
 

10. Modifiers on TARs: Provider Manual Instructions Enhanced

Instructions for entering one or more modifiers on 50-1 Treatment Authorization Request (TAR) forms are updated in the TAR Completion section of the Part 2 Medi-Cal provider manual.

This information is reflected in the following provider manual(s):

Provider Manual(s) Page(s) Updated
Adult Day Health Care Centers
Audiology and Hearing Aids
Chronic Dialysis Clinics
Clinics and Hospitals
Durable Medical Equipment
General Medicine
Heroin Detoxification
Home Health Agencies/Home and Community-Based Services
Hospice Care Centers
Inpatient Services
Medical Transportation
Obstetrics
Orthotics and Prosthetics
Pharmacy
Psychological Services
Rehabilitation Clinics
Therapies
tar comp (9)
Print Article | Return to Top
 

11. CCS Service Code Groupings Update

The following code has been end-dated from the California Children’s Services (CCS) Service Code Groupings (SCGs).

Added Codes:
Effective Date Code
June 1, 2018 HCPCS code J3590

Reminder:

SCG 02 includes all the codes in SCG 01, plus additional codes applicable only to SCG 02. SCG 03 includes all the codes in SCG 01 and SCG 02, plus additional codes applicable only to SCG 03. SCG 07 includes all the codes in SCG 01 plus additional codes applicable only to SCG 07.

This information is reflected in the following provider manual(s):

Provider Manual(s) Page(s) Updated
Audiology and Hearing Aids
Chronic Dialysis Clinics
Clinics and Hospitals
Durable Medical Equipment
General Medicine
Home Health Agencies/Home and Community-Based Services
Inpatient Services
Local Educational Agency
Medical Transportation
Obstetrics
Orthotics and Prosthetics
Pharmacy
Psychological Services
Rehabilitation Clinics
Therapies
Vision Care
cal child ser (1, 2)
Print Article | Return to Top
 

12. Authorized Drug Manufacturer Labeler Codes Update

The Drugs: Contract Drugs List Part 5 – Authorized Drug Manufacturer Labeler Codes section has been updated as follows.

Terminations, effective July 1, 2018
NDC Labeler Code Contracting Company’s Name
63032 STIEFEL LABORATORIES

This information is reflected in the following provider manual(s):

Provider Manual(s) Page(s) Updated
Adult Day Health Care Centers
AIDS Waiver Program
Chronic Dialysis Clinics
Clinics and Hospitals
Expanded Access to Primary Care Program
General Medicine
Heroin Detoxification
Home Health Agencies/Home and Community-Based Services
Hospice Care Program
Multipurpose Senior Services Program
Obstetrics
Pharmacy
Rehabilitation Clinics
drugs cdl p5 (14)
Print Article | Return to Top
 

13. Medi-Cal List of Contract Drugs

p>The following provider manual section(s) have been updated: Drugs: Contract Drugs List Part 1 – Prescription Drugs and Drugs: Contract Drugs List Part 4 – Therapeutic Classifications.

A summary of drugs that have been added or changed is shown below. For additional information, click on the link to the manual section and scroll to the page indicated, or use the find feature to search for the particular drug.

Added Drug(s)
Effective Date Drug Summary of Changes Page(s) Updated
July 1, 2018 EFAVIRENZ/ LAMIVUDINE/ TENOFOVIR DISOPROXIL FUMARATE Drug added, administration added, restriction added drugs cdl p1b (1)

Changed Drug(s)
Effective Date Drug Summary of Changes Page(s) Updated
January 2, 2018 BRIGATINIB Administration added, note added drugs cdl p1a (24)
August 1, 2018 DESOGESTREL AND ETHINYL ESTRADIOL Restriction changed drugs cdl p1a (54)
August 1, 2018 DROSPIRENONE/ ETHINYL ESTRADIOL/ LEVOMEFOLATE CALCIUM Restrictions changed drugs cdl p1a (65)
August 1, 2018 ESTRADIOL VALERATE/ DIENOGEST Restrictions changed drugs cdl p1b (11)
August 1, 2018 ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOL Restriction changed drugs cdl p1b (13)
August 1, 2018 LEVONORGESTREL AND ETHINYL ESTRADIOL Restriction changed drugs cdl p1b (55)
August 1, 2018 NORETHINDRONE Restriction changed drugs cdl p1c (8)
August 1, 2018 NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL Restriction changed drugs cdl p1c (8)
August 1, 2018 NORETHINDRONE AND ETHINYL ESTRADIOL Restriction changed drugs cdl p1c (9)
August 1, 2018 NORETHINDRONE AND MESTRANOL Restriction changed drugs cdl p1c (10)
August 1, 2018 NORGESTIMATE AND ETHINYL ESTRADIOL Restriction changed drugs cdl p1c (11)
August 1, 2018 NORGESTREL AND ETHINYL ESTRADIOL Restriction changed drugs cdl p1c (11)
Print Article | Return to Top
 

14. PE4PW Applicants: Manual Enrollment and Paper Claims to be Discontinued

Effective October 31, 2018, the Department of Health Care Services (DHCS) is discontinuing the manual enrollment and paper claim processes for assisting individuals to apply for the Presumptive Eligibility for Pregnant Women (PE4PW) program.

PE4PW qualified providers (QPs) who assist individuals to apply should discontinue use of the paper MC 263, Application for Presumptive Eligibility for Pregnant Women Program, and shred old unused forms. Providers will use, instead, the electronic application through the PE4PW web Portal. A printable version (MC 263-P) to gather information from applicants prior to submission of the electronic application is available in English and Spanish in the Transactions area of the Medi-Cal website.

The transition period for existing providers and their staff to move from the manual (paper) process to the previously announced web Portal electronic enrollment process, expires on October 31, 2018.

Claims submitted with paper MC 263 PE Proof of Eligibility identification cards for dates of service on or after January 1, 2019, are not reimbursable. Claims submitted using the paper PE Proof of Eligibility card will only be valid for dates of service prior to January 1, 2019. For dates of service on or after January 1, 2019, claims with the PE Proof of Eligibility identification card will deny.

Qualified providers who are not using the electronic real-time enrollment process are encouraged to transition and minimize impact to their business operations. Requirements and changes for PE4PW are:

Questions concerning enrollment, computer based training and other Presumptive Eligibility for Pregnant Women issues can be sent to PE@dhcs.ca.gov.

Guidelines and instructions for enrolling applicants are available in the Presumptive Eligibility for Pregnant Women (PE4PW) Application Web Portal User Guide.

Providers are encouraged to watch for PE4PW updates in the NewsFlash area on the Medi-Cal website. Providers should also subscribe to the Medi-Cal Subscription Service (MCSS) to receive timely notifications related to PE4PW by completing the MCSS Subscriber Form on the Medi-Cal website.

Print Article | Return to Top
 

15. Chemical Pathology CPT-4 and ICD-10-CM Diagnosis Code Pairings Updated

Effective retroactively for dates of service on or after October 1, 2015, the following CPT-4 and ICD-10-CM diagnosis code pairings may no longer be billed together:

CPT-4 Code ICD-10-CM Diagnosis Codes
82607 Z98.891
82728 C4A.0 – C4A.9, C7B.1, E03.5, F45.8, G73.1, K91.86, T80.910D, T80.910S, T80.919D, T80.919S
83001 E03.5, E07.81, M33.02, M33.12, M34.82, M35.03, Q87.82
83876 I23.0 – I23.8
84146 E10.65, E11.65, E13.65
86304 C48.0, C51.0 – C51.2, C51.9, C52, C53.1 – C54.0, C54.8, C55, C57.10 – C57.3, C57.9 – C75.9, C76.0 – C79.52, D06.0 – D07.39, N83.10 – N83.299, R19.00, Z08

Additionally, CPT-4 code 86304 (immunoassay for tumor antigen, quantitative; CA 125) may be billed with ICD-10-CM diagnosis codes C45.1 or D39.9, among other ICD-10-CM diagnosis codes that can be found in the Pathology: Chemistry section in the appropriate Part 2 manual.

An Erroneous Payment Correction (EPC) will be implemented to reprocess affected claims. No action is required of providers.

This information is reflected in the following provider manual(s):

Provider Manual(s) Page(s) Updated
Chronic Dialysis Clinics
Clinics and Hospitals
General Medicine
Obstetrics
path chem (3, 4, 6, 8–10)
Print Article | Return to Top
 

16. Provider Orientation

Family PACT

Medi-Cal providers applying to become a Family Planning, Access, Care and Treatment (Family PACT) provider are required to attend a Provider Orientation per Welfare and Institutions Code (W&I Code), Section (§) 24005(k). The Provider Orientation training is delivered online and in person and includes information on comprehensive family planning, program benefits and services, client eligibility, provider responsibilities and compliance.

Each provider's service location is required to be certified for enrollment in the Family PACT Program. Applicants who are enrolled in Medi-Cal and in good standing or are pending Medi-Cal enrollment and who have submitted a Family PACT application packet may complete the Provider Orientation to certify a site for enrollment.

Each service location must designate one eligible representative to be the site certifier. The site certifier cannot certify multiple sites.

The medical director, physician, nurse practitioner or certified nurse midwife who is responsible for overseeing the family planning services rendered at the location to be enrolled is eligible to certify the site.

Provider Orientation details and registration information is posted on the Family PACT website at www.familypact.org.

Upcoming In-Person Orientation

Oakland
September 21, 2018
10:00 a.m. – 2:00 p.m.
California Endowment
2000 Franklin Street
Oakland, CA 94612

Please contact the Office of Family Planning by phone (916) 650-0414 or email us at ProviderServices@dhcs.ca.gov if you have any questions regarding the orientation process.

Print Article | Return to Top
 

17. October 2018 Medi-Cal Provider Seminar

The October Medi-Cal provider seminar is scheduled for October 16 – 17, 2018, at the Crown Plaza in Concord, California. Providers can access a class schedule for the seminar by visiting the Provider Training web page of the Medi-Cal Learning Portal (MLP) and clicking the seminar date(s) they would like to attend. Providers may RSVP by logging in to the MLP.

Throughout the year, the Department of Health Care Services (DHCS) and the DHCS Fiscal Intermediary (FI) for Medi-Cal conduct Medi-Cal training seminars. These seminars, which target both novice and experienced providers and billing staff, cover the following topics:

Providers must register by October 2, 2018, to receive a hard copy of the Medi-Cal provider training workbooks on the date(s) of training. After October 2, 2018, the workbooks will be available only by download on the Medi-Cal Provider Training Workbooks page of the Medi-Cal website.

Note:

Wi-Fi will not be provided at the seminar. Please plan accordingly.

Providers that require more in-depth claim and billing information have the option to receive one-on-one claims assistance, which is available at all seminars, in the Claims Assistance Room.

Providers may also schedule a custom billing workshop. On the Lookup Regional Representative web page, enter the ZIP code for the area you wish to search and click the “Enter ZIP Code” button. The name of the designated field representative for your area will appear on the map. To contact a regional representative, providers must first contact the Telephone Service Center (TSC) at 1-800-541-5555 and request to be contacted by a representative.

Providers are encouraged to bookmark the Provider Training web page and refer to it often for current seminar information.

Print Article | Return to Top
 

18. Electronic SAR Now Supports Attachments

California Children’s Services (CCS) and Genetically Handicapped Persons Program (GHPP) providers can now submit Service Authorization Requests (SARs) in an electronic format (eSAR) with attachments. Attachments must be in format of PDF, JPG or TIF. Attachments must be less than 15 megabytes (MB) in size, with the sum of all attachments being less than 150 MB. This feature aims to eliminate the paper SAR process for providers with internet connectivity.

To submit eSARs, providers must:

Then, select one of the available options to submit:

Registered providers and clearinghouses can complete and submit the eSAR requests on behalf of the providers and facilities in their network.

Paper SAR submissions remain an option for low-volume SAR providers or submitters who may have technical limitations or practical reasons to do so.

Providers interested in learning more about eSAR submissions should contact the CMS Net Help Desk at cmshelp@dhcs.ca.gov or 1-866-685-8449 for helpful guidance and additional information.

This information is reflected in the following provider manual(s):

Provider Manual(s) Page(s) Updated
Audiology and Hearing Aids
Chronic Dialysis Clinics
Clinics and Hospitals
Durable Medical Equipment
General Medicine
Home Health Agencies/Home and Community-Based Services
Inpatient Services
Local Educational Agency
Medical Transportation
Obstetrics
Orthotics and Prosthetics
Pharmacy
Psychological Services
Rehabilitation Clinics
Therapies
Vision Care
cal child sar (12); genetic (4)
Print Article | Return to Top
 

19. Get the Latest Medi-Cal News: Subscribe to MCSS Today

MCSS Logo

The Medi-Cal Subscription Service (MCSS) is a free service that keeps you up-to-date on the latest Medi-Cal news. Subscribers receive subject-specific emails shortly after urgent announcements and other updates post on the Medi-Cal website.

Subscribing is simple and free!

  1. Go to the MCSS Subscriber Form

  2. Enter your email address and ZIP code and select a subscriber type

  3. Customize your subscription by selecting subject areas for NewsFlash announcements, Medi-Cal Update bulletins and/or System Status Alerts

After submitting the form, a welcome email will be sent to the provided email address. If you are unable to locate the welcome email in your inbox, check your junk email folder.

For more information about MCSS, please visit the MCSS Help page.

Print Article | Return to Top
 

20. Provider Manual Revisions

Pages updated due to ongoing provider manual revisions:

Print Article | Return to Top


Note:

If you cannot view the MS Word or PDF (Portable Document Format) documents correctly, please visit the Web Tool Box to link to a download site for the appropriate reader.